Nom du produit:(R)-1-(3-Fluorophenyl)ethylamine

IUPAC Name:(1R)-1-(3-fluorophenyl)ethan-1-amine

CAS:761390-58-3
Formule moléculaire:C8H10FN
Pureté:95%+
Numéro de catalogue:CM117536
Poids moléculaire:139.17

Unité d'emballage Stock disponible Prix($) Quantité
CM117536-5g in stock ũŵȺ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:761390-58-3
Formule moléculaire:C8H10FN
Point de fusion:-
Code SMILES:N[C@@H](C1=CC=CC(F)=C1)C
Densité:
Numéro de catalogue:CM117536
Poids moléculaire:139.17
Point d'ébullition:
N° Mdl:MFCD06761859
Stockage:Keep in dark place, inert atmosphere, store at 2-8°C.

Category Infos

Benzenes
Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.

Column Infos

Nitrogen Compounds
Nitrogen compounds can be classified as mineral or organic. Mineral compounds are essentially formed by the ammonium ion (NH4+), which is generated when ammonium salts are dissolved in water. Organic compounds, in contrast, are carbon and hydrogen compounds that contain a nitrogen atom. All organic nitrogen-containing compounds can be considered as derivatives of ammonia in which one or more hydrogen atoms are substituted by hydrocarbon radicals.
SE-9
SE-9 is a novel dual-targeting SOS1/EGFR inhibitor that represents a promising treatment strategy for prostate cancer.
Multitarget medications represent an appealing therapy against the disease with multifactorial abnormalities─cancer. Therefore, simultaneously targeting son of sevenless 1 (SOS1) and epidermal growth factor receptor (EGFR), two aberrantly expressed proteins crucial for the oncogenesis and progression of prostate cancer, may achieve active antitumor effects.